Evolent Health's Standardized, Formulaic Pricing Approaches to Help Manage Volatility Going Forward, RBC Says

MT Newswires Live08-26

Evolent Health (EVH) has developed standardized and formulaic pricing methods that will help the company "manage volatility going forward" as it also reportedly received takeover interest from several private equity firms, RBC Capital Markets said in a note Monday.

The company has a "series" of mechanisms for renegotiating pricing to offset the change in cost profile as it is planning to reprice its risk-bearing performance suite contracts to align with changes throughout its "Medicaid and MA health plan partners," analysts Sean Dodge and Thomas Kelliher said.

"While there are some nuances to the various negotiations, per mgmt, it really is just a matter of adjusting PMPM [per member per month] rates," the analysts wrote.

Evolent received takeover interest from private equity firms and healthcare services providers including KKR (KKR), TPG (TPG), Elevance Health (ELV), and Clayton Dubilier & Rice, Reuters reported Thursday.

RBC said that the bidders involved in the takeover "make sense" as TPG was an early investor in Evolent, while Elevance and CD&R formed a partnership earlier in 2024.

The brokerage maintained its outperform rating and $42 price target on the company's stock.

Price: 32.56, Change: -0.41, Percent Change: -1.24

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2462917298?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-26 23:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2462917298","market":"nz","top_or_hot":-1,"title":"Evolent Health's Standardized, Formulaic Pricing Approaches to Help Manage Volatility Going Forward, RBC Says","media":"MT Newswires Live","content":"<html><body><p> Evolent Health (EVH) has developed standardized and formulaic pricing methods that will help the company \"manage volatility going forward\" as it also reportedly received takeover interest from several private equity firms, RBC Capital Markets said in a note Monday.</p><p>The company has a \"series\" of mechanisms for renegotiating pricing to offset the change in cost profile as it is planning to reprice its risk-bearing performance suite contracts to align with changes throughout its \"Medicaid and MA health plan partners,\" analysts Sean Dodge and Thomas Kelliher said.</p><p>\"While there are some nuances to the various negotiations, per mgmt, it really is just a matter of adjusting PMPM [per member per month] rates,\" the analysts wrote.</p><p>Evolent received takeover interest from private equity firms and healthcare services providers including KKR (KKR), TPG (TPG), <a href=\"https://laohu8.com/S/ELV\">Elevance Health</a> (ELV), and Clayton Dubilier &amp; Rice, Reuters reported Thursday.</p><p>RBC said that the bidders involved in the takeover \"make sense\" as TPG was an early investor in Evolent, while Elevance and CD&amp;R formed a partnership earlier in 2024.</p><p>The brokerage maintained its outperform rating and $42 price target on the company's stock.</p><p>Price: 32.56, Change: -0.41, Percent Change: -1.24</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Evolent Health's Standardized, Formulaic Pricing Approaches to Help Manage Volatility Going Forward, RBC Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEvolent Health's Standardized, Formulaic Pricing Approaches to Help Manage Volatility Going Forward, RBC Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-26 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Evolent Health (EVH) has developed standardized and formulaic pricing methods that will help the company \"manage volatility going forward\" as it also reportedly received takeover interest from several...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0048573561.USD","symbol_name":"FIDELITY AMERICA \"A\" (USD) INC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2462917298","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2462917298","pubTimestamp":1724686291,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Evolent Health  has developed standardized and formulaic pricing methods that will help the company \"manage volatility going forward\" as it also reportedly received takeover interest from several private equity firms, RBC Capital Markets said in a note Monday.The company has a \"series\" of mechanisms for renegotiating pricing to offset the change in cost profile as it is planning to reprice its risk-bearing performance suite contracts to align with changes throughout its \"Medicaid and MA health plan partners,\" analysts Sean Dodge and Thomas Kelliher said.\"While there are some nuances to the various negotiations, per mgmt, it really is just a matter of adjusting PMPM [per member per month] rates,\" the analysts wrote.Evolent received takeover interest from private equity firms and healthcare services providers including KKR , TPG , Elevance Health , and Clayton Dubilier & Rice, Reuters reported Thursday.RBC said that the bidders involved in the takeover \"make sense\" as TPG was an early in","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","TPG.AU":"TPG TELECOM LTD","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU1670628061.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) INC","LU0068578508.USD":"First Eagle Amundi International Cl AU-C USD","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU2108987350.USD":"UBS (LUX) EQUITY SICAV GLOBAL OPPORTUNITY SUSTAINABLE (USD) \"P\" (USD) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME  \"AA\" (SGDHDG) INC","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU0053671581.USD":"摩根大通美国小盘成长股 A(dist)","LU1489326972.SGD":"First Eagle Amundi International AHS-MD SGD-H","KKR":"KKR & Co L.P.","LU2505996509.AUD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (AUDHDG) INC","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU2505996681.GBP":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (GBPHDG) INC","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","BK4202":"服装、服饰与奢侈品","LU0882574055.USD":"富达全球健康医疗A ACC","FORD":"福沃德工业","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","BK7042":"综合电信业务","LU1548497426.USD":"安联环球人工智能AT Acc","LU0985489474.SGD":"First Eagle Amundi International AHS-C SGD-H","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","ELV":"Elevance Health","LU2592432038.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"A\" (USD) ACC","TPG":"TPG, Inc.","LU0878866978.SGD":"First Eagle Amundi International AHS-QD SGD-H","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","EVH":"Evolent Health Inc","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU1815333072.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"AUP\" (USD) INC","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","LU0433182093.SGD":"First Eagle Amundi International AS-C SGD","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU0557290698.USD":"施罗德环球可持续增长基金","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC"},"translate_title":"加拿大皇家银行表示，Evolent Health的标准化、公式化定价方法有助于管理未来的波动性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TPG.AU":1,"EVH":1,"FORD":1,"ELV":0.9,"KKR":0.9,"TPG":0.9},"content_text":"Evolent Health (EVH) has developed standardized and formulaic pricing methods that will help the company \"manage volatility going forward\" as it also reportedly received takeover interest from several private equity firms, RBC Capital Markets said in a note Monday.The company has a \"series\" of mechanisms for renegotiating pricing to offset the change in cost profile as it is planning to reprice its risk-bearing performance suite contracts to align with changes throughout its \"Medicaid and MA health plan partners,\" analysts Sean Dodge and Thomas Kelliher said.\"While there are some nuances to the various negotiations, per mgmt, it really is just a matter of adjusting PMPM [per member per month] rates,\" the analysts wrote.Evolent received takeover interest from private equity firms and healthcare services providers including KKR (KKR), TPG (TPG), Elevance Health (ELV), and Clayton Dubilier & Rice, Reuters reported Thursday.RBC said that the bidders involved in the takeover \"make sense\" as TPG was an early investor in Evolent, while Elevance and CD&R formed a partnership earlier in 2024.The brokerage maintained its outperform rating and $42 price target on the company's stock.Price: 32.56, Change: -0.41, Percent Change: -1.24","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2462917298"}